CD69 and neoplasm: Consistent with tumor antigen exposure, we observed increased frequencies of in vivo-stimulated MM CD4+CD69+ T cells, although exhibiting lower potential to respond to further in vitro polyclonal stimulation, thus indicating a dysfunctional phenotype of PB CD4+ T cells.